These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36454662)
41. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Anselmi M; Borbély A; Figueras E; Michalek C; Kemker I; Gentilucci L; Sewald N Chemistry; 2021 Jan; 27(3):1015-1022. PubMed ID: 32955139 [TBL] [Abstract][Full Text] [Related]
42. Design and activity of multifunctional fibrils using receptor-specific small peptides. Ohga Y; Katagiri F; Takeyama K; Hozumi K; Kikkawa Y; Nishi N; Nomizu M Biomaterials; 2009 Dec; 30(35):6731-8. PubMed ID: 19765823 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3. Colombo R; Mingozzi M; Belvisi L; Arosio D; Piarulli U; Carenini N; Perego P; Zaffaroni N; De Cesare M; Castiglioni V; Scanziani E; Gennari C J Med Chem; 2012 Dec; 55(23):10460-74. PubMed ID: 23140358 [TBL] [Abstract][Full Text] [Related]
44. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation. Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110 [TBL] [Abstract][Full Text] [Related]
45. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine). Merkel OM; Germershaus O; Wada CK; Tarcha PJ; Merdan T; Kissel T Bioconjug Chem; 2009 Jun; 20(6):1270-80. PubMed ID: 19476331 [TBL] [Abstract][Full Text] [Related]
46. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Cody V; Davis PJ; Davis FB Steroids; 2007 Feb; 72(2):165-70. PubMed ID: 17166537 [TBL] [Abstract][Full Text] [Related]
47. Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenase. Dayan A; Fleminger G; Ashur-Fabian O Oncogene; 2019 Jun; 38(25):5050-5061. PubMed ID: 30872792 [TBL] [Abstract][Full Text] [Related]
48. Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells. Lanza P; Felding-Habermann B; Ruggeri ZM; Zanetti M; Billetta R Blood Cells Mol Dis; 1997 Aug; 23(2):230-41. PubMed ID: 9268674 [TBL] [Abstract][Full Text] [Related]
49. Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem. Rowedder JE; Ludbrook SB; Slack RJ SLAS Discov; 2017 Sep; 22(8):962-973. PubMed ID: 28414923 [TBL] [Abstract][Full Text] [Related]
50. Synthesis of Modified RGD-Based Peptides and Their in vitro Activity. Hamdan F; Bigdeli Z; Asghari SM; Sadremomtaz A; Balalaie S ChemMedChem; 2019 Jan; 14(2):282-288. PubMed ID: 30506622 [TBL] [Abstract][Full Text] [Related]
52. Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. Wu PL; Lee SC; Chuang CC; Mori S; Akakura N; Wu WG; Takada Y J Biol Chem; 2006 Mar; 281(12):7937-45. PubMed ID: 16407244 [TBL] [Abstract][Full Text] [Related]
53. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site. Fujita M; Takada YK; Takada Y PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099 [TBL] [Abstract][Full Text] [Related]
54. In silico studies, synthesis and binding evaluation of substituted 2-pyrrolidinones as peptidomimetics of RGD tripeptide sequence. Toum V; Bolley J; Lalatonne Y; Barbey C; Motte L; Lecouvey M; Royer J; Dupont N; Pérard-Viret J Eur J Med Chem; 2015 Mar; 93():360-72. PubMed ID: 25721024 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and assay of retro-α4β1 integrin-targeting motifs. Dattoli SD; De Marco R; Baiula M; Spampinato S; Greco A; Tolomelli A; Gentilucci L Eur J Med Chem; 2014 Feb; 73():225-32. PubMed ID: 24412498 [TBL] [Abstract][Full Text] [Related]
56. Molecular determinants of arg-gly-asp ligand specificity for beta3 integrins. Kunicki TJ; Annis DS; Felding-Habermann B J Biol Chem; 1997 Feb; 272(7):4103-7. PubMed ID: 9020120 [TBL] [Abstract][Full Text] [Related]
57. Integrin αvβ3 promotes infection by Japanese encephalitis virus. Fan W; Qian P; Wang D; Zhi X; Wei Y; Chen H; Li X Res Vet Sci; 2017 Apr; 111():67-74. PubMed ID: 28043010 [TBL] [Abstract][Full Text] [Related]
58. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies. Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523 [TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys). Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771 [TBL] [Abstract][Full Text] [Related]